SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Opsens Inc. OPSSF OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • CA • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Opsens Inc. (OPSSF) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $2.14. It has a SharesGrow Score of 45/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Financials: revenue is $48M, +18.8%/yr average growth. Net income is $12M (loss), growing at -273.4%/yr. Net profit margin is -25.7% (negative). Gross margin is 57.9% (+4.9 pp trend).

Balance sheet: total debt is $9M against $34M equity (Debt-to-Equity (D/E) ratio 0.27, conservative). Current ratio is 4.42 (strong liquidity). Debt-to-assets is 18.1%. Total assets: $51M.

Analyst outlook: 1 / 1 analysts rate OPSSF as buy (100%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 48/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 50/100 (Partial), Future 100/100 (Pass), Income 10/100 (Fail).

OPSSF SharesGrow Score Overview

55/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 0/100

Valuation — P/E, PEG, Forward PEG

GROWTH 48/100

Financials — average growth

PAST 0/100

strong — trend

HEALTH 67/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 50/100

Gross margin is + market cap

FUTURE 100/100

Analyst outlook — as buy

INCOME 10/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — OPSSF

No analyst coverage available for this stock.

OPSSF: +18.8%/yr revenue is, -273.4%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

No analyst coverage available for this stock.

Balance sheet OPSSF: Debt-to-Equity (D/E) ratio 0.27 (conservative), Current ratio is 4.42 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

OPSSF: Gross margin is 57.9% (+4.9 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 50/100. ≥ 70 = Pass.

View details →

Analyst outlook: 1 / 1 analysts rate OPSSF as buy (100%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

OPSSF: Net profit margin is -25.7%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range0.97-2.14

Volume25.7K

Avg Volume (30D)118.46K

Market Cap$247.43M

Beta (1Y)0.32

Share Statistics

IPO Date2012-08-03

Employees293

CEOLouis Laflamme CPA, CPA

Financial Highlights & Ratios

Revenue (TTM)$48.35M

Gross Profit$27.97M

EBITDA$-9.73M

Net Income$-12.4M

Operating Income$-11.83M

Total Cash$18.1M

Total Debt$9.21M

Net Debt$-8.9M

Total Assets$50.83M

Price / Sales (P/S)5.12

Analyst Forecast

Rating ConsensusBuy

Analysts Covering1

Buy 100% Hold 0% Sell 0%

Company Info

CountryCA

ExchangeOther OTC

CurrencyUSD

Price Chart

OPSSF

Opsens Inc. ↗ · Other OTC

Healthcare • Medical - Instruments & Supplies

0.97 52WK RANGE 2.14

People Also View

Intuitive Surgical, Inc.

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

STAAR Surgical Company

Microbot Medical Inc.

SmileDirectClub, Inc.

Bionano Genomics, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message